KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zoetis (ZTS) Shares Outstanding (Diluted Average) (2016 - 2025)

Zoetis (ZTS) has disclosed Shares Outstanding (Diluted Average) for 13 consecutive years, with $443.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) fell 2.83% to $443.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $443.2 million, a 2.83% decrease, with the full-year FY2024 number at $454.8 million, down 1.61% from a year prior.
  • Shares Outstanding (Diluted Average) was $443.2 million for Q3 2025 at Zoetis, down from $445.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $477.9 million in Q1 2021 to a low of $443.2 million in Q3 2025.
  • A 5-year average of $463.8 million and a median of $463.8 million in 2023 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): dropped 0.23% in 2021, then fell 2.83% in 2025.
  • Zoetis' Shares Outstanding (Diluted Average) stood at $476.7 million in 2021, then decreased by 1.33% to $470.4 million in 2022, then dropped by 1.73% to $462.3 million in 2023, then decreased by 1.61% to $454.8 million in 2024, then dropped by 2.56% to $443.2 million in 2025.
  • Per Business Quant, the three most recent readings for ZTS's Shares Outstanding (Diluted Average) are $443.2 million (Q3 2025), $445.5 million (Q2 2025), and $448.0 million (Q1 2025).